Cómo citar este artículo: Ortega Pacific EJ, Rodríguez Rodríguez A. Control de la miopía con ortoqueratología. Cienc Tecnol Salud Vis Ocul. 2017;15(1):69-78. doi: http://dx.doi.org/10.19052/sv.3905 RESUMEN La ortoqueratología ha tenido un gran auge en los últimos años, debido a la aparición de nuevos materiales y diseños que han facilitado su aplicación; por esta razón, se planteó desarrollar una revisión que permitiera analizarla desde aquellos pacientes en quienes se ha usado. Objetivos: mostrar la evidencia científica del uso de la ortoqueratología para el control de la miopía. Materiales y métodos: revisión bibliométrica de 50 artículos científicos escritos entre 1999 y 2015, con grado de recomendación B y nivel de evidencia II-3, según la escala United States Preventive Services Task Force (USPTS). Se consideraron las variables edad, defecto refractivo, longitud axial y curvatura corneal. Resultados: el 47 % de los pacientes eran menores de 15 años de edad. Las modificaciones más importantes a través de la ortoqueratología se encontraron en pacientes con valores refractivos menores de −4,00 D (80 %); al mes de tratamiento se presentaron reducciones en promedio de −3,11 D. En su mayoría, el diseño de los lentes utilizados fue de geometría inversa, con materiales con permeabilidad mayor a 100. Conclusiones: la ortoqueratología retarda la progresión de la miopía; esto se evidencia en el 100 % de los artículos analizados. Hay mayor eficacia en el control de la miopía en valores bajos (miopías de hasta 4 D, según Borish): un 55 % con miopías de −0,25 a −1,00 D, mientras que el 45 % restante se reparte con poderes entre −1,25 y −7,00 D.Palabras clave: ortoqueratología, moldeamiento corneal, control de la miopía.
Hong Kong Chinese students had a higher prevalence of myopia regardless of whether they studied in local or international schools when compared with other ethnic groups, such as whites. This further supports a genetic input into myopia development.
The purpose of this work was to characterize the development of refractive error in Hong Kong children between the ages of 7 and 12 years. A non self-selected sample of 7-year old children was recruited and followed for 5 years, non-cycloplegic refractions being carried out annually. A life-table was used to determine myopia incidence and prevalence. The mean annual change in the spherical equivalent refraction (SER) was -0.32 D; 75 out of 83 subjects followed for 5 years became less hyperopic or more myopic, the maximum progression occurring between 9 and 11 years of age. The mean change in SER over the 5 years in children who were myopic at age 12 years was significantly greater than that in children who remained non-myopic. The incidence of myopia at age 7-8 years was 9% and at age 11-12 years was 18-20%. At age 7 years the prevalence of progressive myopia was 1.6% and 2.5% of subjects had anisometropia. Any treatment to prevent myopia should start by the age of 6 years and treatment to retard development should commence before age 9 years.
SummaryThe Canon Autoref R-1 is an`open-®eld' autorefractor which has been widely used for research purposes for the past 20 years, but is no longer manufactured. A new autorefractor, the ShinNippon SRW-5000, is now available, and if measures using this instrument are shown to be equally accurate and reliable, is likely to replace the R-1. Here we report on the accuracy and reliability (repeatability and reproducibility) of refraction measures in a paediatric population (from 4 to 8 years of age). Subject numbers were 44 for cycloplegic measures and 53 for non-cycloplegic measures. As would be expected, agreement with cycloplegic refraction and reliability were better when SRW-5000 measures were taken using cycloplegia. Repeatability results from the SRW-5000 autorefractor, both with and without cycloplegia were similar to those reported for the Canon R-1. q
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.